Favipiravir

In 2014, favipiravir was approved in Japan to treat cases of influenza that were unresponsive to conventional treatment. Given its efficacy at targeting several strains of influenza, it has been investigated in other countries to treat novel viruses including Ebola and most recently, COVID-19.

9 Likes

LikeAnswersShare

Very early to comment on efficacy of fevipiravir in covid19 Side effects and drug interaction are too worry some Prolongation of qt interval may pose acute cardiac emergency as additive effect of azithromycin or hcqs Anyway worth giving than nothing

Thanx dr Kute Ankush
0

Informative post but not conclusive ,some pt with covid 19 Infection shows good results but it is a clinic trial ,after getting reports from all over world it will be conclusive and doses and period of time to short to handle any adverse effects. Regular monitoring and constant evaluation required.

Thanks Dr Shivraj Agarwal
0

View 2 other replies

GOOD.. USEFUL INFORMATION.. LET'S.. WAIT..FOR SOME TIME & .. SEE..MORE.. FOR RESULTS..IN ..COVID-19.. CASES.. PRESENTLY..NO..SUCH..DATA OR INFORMATION AVAILABLE..REGARDING..

Informative

Very good information about faviparavir antiviral drug.very helpful.

@Dr. Kute Ankush @Dr. Seema Shukla @Dr. Kunal Kaushal We are using this as Covid tt since month but the information is valuable and informative

Information

Very useful

Aap se banti hai virus Kyon banta hai Jab Sharir ka digestive system kya hota hai liver infection Hota Hai uric acid jyada badhta hai vajah Wapas Mein Milte Hain donon virus nikalta hai banta hai vah jaldi se theek Nahin Hota Sharir khatm hone lagta hai isliye pahle a dietician ok karo FIR liver ko ok karo uric acid khatm Karo aadami ke sab virus khatm Ho Jaenge

Informative..... Need.more details

Load more answers

Cases that would interest you